Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLA2G4A | P47712 | 16/20 | 0.52 |
| ▸ | PLA2G4B | P0C869 | 1/20 | 0.46 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | THRB | P10828 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2807126 | 0.87 | PLA2G4A (0.50) | PLA2G4APLA2G4B | |
| SCHEMBL2804338 | 0.87 | PLA2G4A (0.50) | PLA2G4APLA2G4B | |
| SCHEMBL2810892 | 0.85 | PLA2G4A (0.66) | PLA2G4A | |
| SCHEMBL3920401 | 0.81 | PLA2G4A (0.52) | PLA2G4APLA2G4B | |
| SCHEMBL2806318 | 0.80 | PLA2G4A (0.58) | PLA2G4ATP53MAPTTHRB | |
| SCHEMBL3931702 | 0.79 | PLA2G4A (0.54) | PLA2G4APLA2G4B | |
| SCHEMBL4002475 | 0.78 | PLA2G4A (0.53) | PLA2G4APLA2G4B | |
| SCHEMBL3920462 | 0.77 | PLA2G4A (0.51) | PLA2G4APLA2G4B | |
| SCHEMBL2806824 | 0.75 | PLA2G4A (0.47) | PLA2G4A | |
| SCHEMBL3919688 | 0.75 | PLA2G4A (0.52) | PLA2G4APLA2G4B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100240718-A1 | NOVEL HETEROARYL-SUBSTITUTED ACETONE DERIVATIVE, SUITABLE FOR INHIBITING PHOSPHOLIPASE A2 | WESTFALISCHE WILHELMS UNIVERSITÄT MÜNSTER (DE) | 2010-09-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100240718-A1 | NOVEL HETEROARYL-SUBSTITUTED ACETONE DERIVATIVE, SUITABLE FOR INHIBITING PHOSPHOLIPASE A2 | PLD2, PLA2G1B, PLA2G4A | PLA2G4A 3/4885PLA2G4B 5/4885TP53 2765/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.